NCT04422249

Brief Summary

The study, entitled "RCT study of laparoscopic middle hepatic venous guidance versus conventional ananatomical hemihepatectomy", was designed to compare the efficacy of two different ananatomical hemihepatectomy procedures under laparoscopy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
95

participants targeted

Target at P50-P75 for not_applicable hepatocellular-carcinoma

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable hepatocellular-carcinoma

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 23, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 23, 2023

Completed
Last Updated

December 26, 2023

Status Verified

December 1, 2023

Enrollment Period

4 years

First QC Date

May 20, 2020

Last Update Submit

December 21, 2023

Conditions

Keywords

Laparoscopic Middle hepatic vein Hepatocellular carcinoma

Outcome Measures

Primary Outcomes (1)

  • Survival rate

    follow-up after the surgery every 3 months, to understand statistics 1-year overall survival、3-year overall survival、1-year disease-free survival、3-year disease-free survival

    3 years

Secondary Outcomes (2)

  • Perioperative results

    Duration perioperation(an expected average of 3 days)

  • intraoperative parameters

    during the operation

Other Outcomes (1)

  • Incidence of postoperative complications

    Duration hospitalization(an expected average of 7 days)

Study Arms (2)

laparoscopic middle hepatic vein guidance hemihepatectomy

EXPERIMENTAL

In theory, the advantages of anatomical hemihepatectomy guided by middle hepatic vein are as follows: 1) correctly guiding the transecting plane of the liver parenchyma can reduce the cross-sectional area of the liver and avoid damaging the vascular ducts of the pre-cut liver. so as to reduce the residue of necrotic tissue without blood supply and reduce the occurrence of postoperative complications. 2) active anatomy and exposure of hepatic vein can avoid uncontrollable bleeding after passive injury of hepatic vein, and laparoscopic anatomy has obvious advantage in exposing hepatic vein. 3) it may reduce the early recurrence rate of hepatocellular carcinoma after operation.

Procedure: laparoscopic middle hepatic vein guidance anatomic hemihepatectomy

laparoscopic traditional anatomic hemihepatectomy

ACTIVE COMPARATOR

According to textbooks and the views of some scholars at present, traditional anatomical hepatectomy (non-hepatic vein-guided anatomical hepatectomy) has the following advantages: 1) avoiding exposure of hepatic vein can reduce the probability of injury to the trunk of hepatic vein, thus reduce the risk of massive bleeding during operation; 2) the difficulty of operation is relatively low, and a better short-term and long-term effect can be obtained.

Procedure: laparoscopic middle hepatic vein guidance anatomic hemihepatectomy

Interventions

95 patients with primary HCC were divided into the middle hepatic vein guidance group(n=45) and the traditional group(n=45) according to the odd and even Numbers, and sealed into envelopes.Outcomes were monitored and evaluated during the 3-year follow-up period

Also known as: laparoscopic traditional anatomic hemihepatectomy
laparoscopic middle hepatic vein guidance hemihepatectomylaparoscopic traditional anatomic hemihepatectomy

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the site was limited to the patients who were suitable for dissecting hemihepatectomy;
  • the type of disease was limited to hepatocellular carcinoma;
  • the patients were generally able to tolerate anesthesia, the liver reserve function was good, and the patients were suitable for laparoscopic surgery;
  • child-pugh grade A, no severe liver cirrhosis, portal hypertension, no extrahepatic and extrahepatic metastasis and main vascular invasion;
  • the subjects who participated in this study indicated that they were willing to accept the two surgical methods and agreed to be randomly divided into groups during the operation;
  • ≤ age ≤ 70, male or female.

You may not qualify if:

  • preoperative liver function Child-pugh grade B or C;
  • patients with poor general condition and could not tolerate pneumoperitoneum or anesthesia;
  • patients with severe liver cirrhosis, portal hypertension and lesions invading liver porta;
  • patients with other treatment methods such as radio frequency ablation in addition to dissecting hepatectomy;
  • repeated abdominal operations resulting in severe abdominal adhesion, unable to perform laparoscopic hepatectomy; male and female are not limited

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southwest Hospital

Chongqing, Chongqing Municipality, 400038, China

RECRUITING

MeSH Terms

Conditions

Carcinoma, Hepatocellular

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver Diseases

Central Study Contacts

Shuguo Zheng, M.D.

CONTACT

Shuguo Zheng, Zheng

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Two different treatments are conducted on the participant base on the randomized choices
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Hepatobiliary Surgery Institute; Chief Physician; Administrator of laparoscopic department

Study Record Dates

First Submitted

May 20, 2020

First Posted

June 9, 2020

Study Start

December 23, 2019

Primary Completion

December 23, 2023

Study Completion

December 23, 2023

Last Updated

December 26, 2023

Record last verified: 2023-12

Locations